Ignite Creation Date:
2025-12-25 @ 1:59 AM
Ignite Modification Date:
2026-01-06 @ 9:22 AM
Study NCT ID:
NCT00727194
Status:
TERMINATED
Last Update Posted:
2019-09-24
First Post:
2008-07-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis
Sponsor:
Alexion Pharmaceuticals, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
C08-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None